Menu

Image of the Day: Where Have All The Pigeons Gone? 

A new study sheds light on how the most abundant bird in North America went extinct. 

Dec 8, 2017
The Scientist Staff, The Scientist Staff

Two specimens of passenger pigeon (Ectopistes migratorius), an extinct pigeon species that was endemic to North AmericaBRIAN BOYLE, MPA, FPPO PHOTO COPYRIGHT ROMThe passenger pigeon (Ectopistes migratorius) was once the most abundant bird in North America. Its population is estimated to have numbered between 3 billion and 5 billion before widespread hunting drove it to extinction in the late 19th century. 

How such a large, stable population could abruptly vanish has long puzzled scientists. Now, a genomic analysis of conserved pigeon specimens sheds light on how the extinction occurred. Researchers were able to show that the passenger pigeon population did not have much genetic diversity compared to living pigeon species, which they believe made it less able to survive human pressures. 

G.G.R. Murray et al., “Natural selection shaped the rise and fall of passenger pigeon genomic diversity,” Science, doi:10.1126/science.aao0960, 2017. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.